News
Lilly's BIL Shows Superiority To Insulin Glargine In Reducing HbA1c
www.finanznachrichten.de
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co.'s (LLY) basal insulin peglispro or BIL consistently demonstrated superior hemoglobin A1c (HbA1c) ...
Eli Lilly's BIL studies show superiority to insulin glargine across...
test.pharmabiz.com
Eli Lilly's BIL studies show superiority to insulin glargine across multiple measures in people with type 1 diabetes
Lilly : BIL Shows Superiority To Insulin Glargine Across MM In Type 1...
www.rttnews.com
In newly released Phase III trial data, Eli Lilly and Company's (LLY) basal insulin peglispro or BIL demonstrated statistically significantly lower hemoglobin A1c or
sortiert nach Relevanz / Datum